Product image of Minoxidil Cooper 2% (Minoxidil) supplied by GNH India

Minoxidil Cooper 2%

Active Ingredient:
Minoxidil
Origin:
EU

Minoxidil Cooper 2% (Minoxidil)

Minoxidil, the active ingredient in Minoxidil Cooper 2%, is a potassium channel opener presented as a 2% w/v topical solution for scalp use. It is indicated for the treatment of androgenetic alopecia in both men and women and may also be employed for other forms of alopecia.

GNH India supplies Minoxidil Cooper 2% as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution across EU and other regulated markets. The product complies with European Union quality standards and is available for bulk procurement.

Manufacturer / TM Owner

Cooperation Pharmaceutique Francaise

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Minoxidil is a potassium channel opener used to address hair loss conditions.
  • Androgenetic alopecia (male pattern): promotes regrowth of scalp hair and increases hair density.
  • Androgenetic alopecia (female pattern): enhances hair thickness and reduces shedding.
  • Alopecia areata: may support hair regrowth in localized patches.
  • Telogen effluvium: may aid in accelerating the return of normal hair growth.

How It Works

  • Minoxidil opens ATP‑sensitive potassium channels in dermal papilla cells, causing hyperpolarization of cell membranes and vasodilation. The resulting increased blood flow delivers nutrients and oxygen to hair follicles, prolonging the anagen (growth) phase and stimulating follicular proliferation, which together support new hair shaft formation.

Side Effects

Topical minoxidil may cause local and systemic adverse reactions, which are categorized by frequency.

Common Side Effects

  • Scalp irritation or itching
  • Dryness and flaking of the applied area
  • Redness or mild erythema at the site of application
  • Unwanted facial hair growth (hypertrichosis)
  • Temporary shedding of existing hair

Serious or Rare Side Effects

  • Severe allergic reaction with swelling of face, lips, or throat
  • Chest pain, rapid heartbeat, or unexplained dizziness
  • Significant drop in blood pressure leading to faintness
  • Persistent swelling or rash beyond the application site
  • Unusual weight gain or fluid retention

Precautions & Warnings

  • Before using Minoxidil Cooper 2% consider the following safety measures.
  • Pregnancy: safety not established; avoid use unless benefits outweigh risks.
  • Breastfeeding: insufficient data; consider alternative therapy.
  • Skin condition: do not apply to irritated, infected, or damaged scalp.
  • Concurrent use: avoid combining with other topical hair products without professional guidance.
  • Systemic absorption: monitor for cardiovascular symptoms in patients with heart disease.
  • Store at room temperature: keep container tightly closed, protect from light and moisture.

Avoid Interactions

Minoxidil may interact with other medicines; awareness of interaction severity helps ensure safe use.

Major Interactions (Avoid)

  • Oral minoxidil: concurrent use may increase systemic exposure leading to hypotension.
  • Other vasodilators (e.g., nitroglycerin): additive blood‑pressure‑lowering effect.
  • Beta‑blockers: may blunt cardiovascular response to systemic absorption.

Moderate Interactions (Monitor Closely)

  • Hair dyes or chemical treatments: may affect minoxidil absorption.
  • Topical steroids: may increase skin irritation when used together.
  • Antihypertensive drugs: monitor blood pressure if systemic absorption occurs.

Frequently Asked Questions

Minoxidil Cooper 2% is a topical solution used to treat androgenetic alopecia in both men and women and may also be applied to other forms of hair loss such as alopecia areata or telogen effluvium. It works by stimulating hair‑follicle activity to promote regrowth and improve hair density.

Minoxidil opens ATP‑sensitive potassium channels in the cells surrounding hair follicles, causing hyperpolarization and vasodilation. The increased blood flow delivers nutrients and oxygen, prolonging the anagen (growth) phase of the hair cycle and encouraging the formation of new hair shafts.

The appropriate dose of Minoxidil Cooper 2% is determined by the prescribing healthcare professional. Typically, the product is applied to the scalp twice daily, but exact instructions, including amount per application, should follow the prescriber’s guidance.

Safety of topical minoxidil during pregnancy or lactation has not been firmly established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks with their healthcare provider before using the product.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Minoxidil is a potassium channel opener, whereas other classes such as finasteride are oral 5‑alpha‑reductase inhibitors. Minoxidil acts locally on the scalp to increase blood flow and follicle activity, while finasteride works systemically to reduce dihydrotestosterone levels. Choice of therapy depends on patient profile, tolerance, and physician recommendation.

Store the product at room temperature, ideally below 25 °C, in its original container. Keep the bottle tightly closed, protect it from direct sunlight, and avoid exposure to moisture. Do not freeze the solution, and keep it out of reach of children.

Apply the solution directly to a dry scalp using the supplied applicator or dropper, typically twice a day. Ensure the scalp is clean and dry before use, and allow the product to dry completely before styling or using other hair products.

Serious risks, though rare, include severe allergic reactions such as swelling of the face, lips, or throat, and systemic cardiovascular effects like chest pain, rapid heartbeat, or a significant drop in blood pressure. If any of these symptoms occur, discontinue use and seek medical attention promptly.

Individuals with known hypersensitivity to minoxidil or any component of the formulation should avoid the product. It is also contraindicated on irritated, infected, or damaged scalp skin, and caution is advised for patients with underlying heart disease or those taking other vasodilators.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Minoxidil

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT